Cargando…

Targeted therapy for hepatocellular carcinoma

The last 3 years have seen the emergence of promising targeted therapies for the treatment of hepatocellular carcinoma (HCC). Sorafenib has been the mainstay of treatment for a decade and newer modalities were ineffective and did not confer any increased therapeutic benefit until the introduction of...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Ao, Yang, Xin-Rong, Chung, Wen-Yuan, Dennison, Ashley R., Zhou, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419547/
https://www.ncbi.nlm.nih.gov/pubmed/32782275
http://dx.doi.org/10.1038/s41392-020-00264-x

Ejemplares similares